A detailed history of Boothbay Fund Management, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 103,493 shares of ANNX stock, worth $721,346. This represents 0.02% of its overall portfolio holdings.

Number of Shares
103,493
Previous 375,276 72.42%
Holding current value
$721,346
Previous $2.69 Million 81.15%
% of portfolio
0.02%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$4.33 - $6.79 $1.18 Million - $1.85 Million
-271,783 Reduced 72.42%
103,493 $507,000
Q1 2024

May 15, 2024

SELL
$4.03 - $7.81 $1.34 Million - $2.6 Million
-332,539 Reduced 46.98%
375,276 $2.69 Million
Q4 2023

Feb 14, 2024

BUY
$1.63 - $4.63 $1.15 Million - $3.28 Million
707,815 New
707,815 $3.21 Million
Q1 2023

May 15, 2023

BUY
$3.74 - $7.46 $3,107 - $6,199
831 Added 5.38%
16,274 $62,000
Q4 2022

Feb 14, 2023

BUY
$4.56 - $6.61 $70,420 - $102,078
15,443 New
15,443 $79,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $332M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.